Earnings History Data for Adaptimmune Therapeutics plc (ADAP) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc is a biopharmaceutical company. The Company is focused on cancer immunotherapy products based on T-cell receptor platform. Adaptimmune Therapeutics plc is based in Abingdon, United Kingdom.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
12-08-2024 PM ADAP Adaptimmune Therapeutics plc 252.24 0.27 0.00 -0.21 Adaptimmune GAAP EPS of $0.05 beats by $0.05, revenue of $128.2M beats by $83.44M
[8/12/2024 7:09 AM]
1.08 0.09 
(8.95%)
1.10 0.11 
(10.79%)
0.42 - 2.05 3,868,265 3,510,000 434,284
15-05-2024 PM ADAP Adaptimmune Therapeutics plc 276.44 -0.18 -0.16 0.01 Adaptimmune GAAP EPS of -$0.03 beats by $0.04, revenue of $5.7M misses by $11.37M
[5/15/2024 7:45 AM]
1.21 0.06 
(5.22%)
1.18 0.03 
(2.61%)
0.42 - 2.05 1,318,569 780,000 67,402
06-03-2024 PM ADAP Adaptimmune Therapeutics 1,471 -0.24 -0.12 0.00 1.72 0.26 
(17.81%)
1.55 0.09 
(6.16%)
0.42 - 1.79 2,059,832 1,560,000 116,068
08-11-2023 PM ADAP Adaptimmune Therapeutics plc 132.81 -0.20 -0.20 -0.24 Adaptimmune GAAP EPS of -$0.03 beats by $0.16, revenue of $7.3M misses by $7.84M
[11/8/2023 7:37 AM]
0.5682 -0.03 
(-4.66%)
0.57 -0.03 
(-4.33%)
0.52 - 2.65 205,371 300,000 31,792
09-08-2023 PM ADAP Adaptimmune Therapeutics plc 142.50 -0.21 -0.17 -0.28 Adaptimmune GAAP EPS of -$0.02 beats by $0.19, revenue of $5.13M misses by $1.54M
[8/9/2023 7:56 AM]
0.85 -0.01 
(-1.16%)
0.0 0.0 
(0.00%)
0.84 - 2.65 476,904 490,000 0
12-05-2023 PM 0:00 AM ET
(May 12)
ADAP Adaptimmune Therapeutics 217.00 0.01 -0.19 0.00 Adaptimmune GAAP EPS of $0.00 beats by $0.14, revenue of $47.6M
[5/12/2023 8:39 AM]
1.37 0.01 
(0.74%)
1.42 0.06 
(4.41%)
1.01 - 2.65 396,651 590,000 3,845
06-03-2023 PM 0:00 AM ET
(Mar 6)
ADAP Adaptimmune Therapeutics plc 265.40 -0.18 -0.25 -0.25 Adaptimmune GAAP EPS of -$0.03 beats by $0.20, revenue of $11.03M beats by $5.95M
[3/6/2023 6:44 AM]
1.33 -0.43 
(-24.43%)
1.38 -0.38 
(-21.59%)
1.01 - 2.65 4,315,111 180,000 435,241
08-11-2022 PM ADAP Adaptimmune Therapeutics plc 259.76 -0.24 -0.28 -0.27 Adaptimmune GAAP EPS of -$0.04 beats by $0.22, revenue of $7M beats by $2.03M
[11/8/2022 8:33 AM]
2.09 0.43 
(25.90%)
1.80 0.14 
(8.43%)
1.01 - 5.95 1,409,268 360,000 11,223
04-08-2022 PM 7:30 AM ET
(Aug 4)
ADAP Adaptimmune Therapeutics plc 294.87 -0.28 -0.28 -0.24 Adaptimmune Non-GAAP EPS of -$0.05 beats by $0.24, revenue of $5.54M misses by $3.16M
[8/4/2022 7:35 AM]
2.31 0.37 
(19.07%)
3.92 -0.40 
(-9.26%)
1.26 - 6.86 496,636 180,000 51,552
09-05-2022 PM 8:00 AM ET
(May 9)
ADAP Adaptimmune Therapeutics plc 279.22 -0.32 -0.26 -0.24 Adaptimmune GAAP EPS of -$0.05 beats by $0.19, revenue of $3.6M misses by $1.4M
[5/9/2022 7:32 AM]
1.55 -0.16 
(-9.36%)
1.71 0.0 
(0.00%)
1.50 - 6.86 787,004 910,000 407
14-03-2022 PM 7:30 AM ET
(Mar 14)
ADAP Adaptimmune Therapeutics plc 295.23 -0.25 -0.22 -0.24 Adaptimmune GAAP EPS of -$0.04, revenue of $1.4M
[3/14/2022 8:05 AM]
1.82 0.0 
(0.00%)
1.85 0.03 
(1.65%)
1.77 - 6.86 1,034,086 1,000,535 4,760
04-11-2021 PM 7:30 AM ET
(Nov 4)
ADAP Adaptimmune Therapeutics plc 841.32 -0.27 0.05 -0.23 Adaptimmune EPS beats by $0.21, beats on revenue
[11/4/2021 7:34 AM]
5.25 -0.22 
(-4.02%)
5.25 0.0 
(0.00%)
3.37 - 7.34 420,698 470,000 206
09-08-2021 AH After the close
(Aug 9)
ADAP Adaptimmune Therapeutics plc 548.91 -0.24 -0.25 -0.24 Adaptimmune EPS beats by $0.20, beats on revenue
[8/9/2021 4:05 PM]
3.57 0.12 
(3.33%)
3.65 0.20 
(5.80%)
3.37 - 10.93 1,327,051 420,000 32,419
06-05-2021 PM 7:30 AM ET
(May 6)
ADAP Adaptimmune Therapeutics plc 831.82 -0.24 -0.25 -0.24 Adaptimmune EPS beats by $0.21, misses on revenue
[5/6/2021 7:32 AM]
4.90 -0.22 
(-4.30%)
4.90 0.0 
(0.00%)
3.36 - 13.40 1,144,335 830,000 950
25-02-2021 PM 7:30 AM ET
(Feb 25)
ADAP Adaptimmune Therapeutics plc 920.93 -0.24 -0.23 -0.28 Adaptimmune EPS beats by $0.19, beats on revenue
[2/25/2021 7:32 AM]
5.97 -0.02 
(-0.33%)
6.02 0.03 
(0.50%)
2.00 - 13.40 535,627 1,182,365 1,548
05-11-2020 PM 7:30 AM ET
(Nov 5)
ADAP Adaptimmune Therapeutics plc 808.62 -0.23 -0.23 -0.37 Adaptimmune EPS beats by $0.19, beats on revenue
[11/5/2020 7:36 AM]
5.31 0.01 
(0.19%)
5.31 0.0 
(0.00%)
0.71 - 13.40 1,130,047 2,352,031 3,101
06-08-2020 PM 7:30 AM ET
(Aug 6)
ADAP Adaptimmune Therapeutics plc 1,390 -0.24 -0.24 -0.42 Adaptimmune EPS beats by $0.20, misses on revenue
[8/6/2020 7:34 AM]
8.50 -0.22 
(-2.52%)
8.70 -0.02 
(-0.23%)
0.71 - 13.40 410,014 667,680 6,947
14-05-2020 PM 7:30 AM ET
(May 14)
ADAP Adaptimmune Therapeutics plc 641.39 -0.24 -0.13 -0.24 Adaptimmune EPS beats by $0.21, misses on revenue
[5/14/2020 7:37 AM]
4.35 -0.19 
(-4.18%)
4.65 0.11 
(2.42%)
0.71 - 6.00 789,373 1,077,558 16,917